Skip to main content

Table 2 THRIVE RCT Compensation Scheme

From: THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer

Months 0–6

Months 7–12

Month 18

Months 24

Months 32

Months 36

Baseline Survey, WisePill charge maintenance

Follow-up survey, WisePill charge maintenance and Return

Follow-up Survey

Follow-up Survey

Follow-up Survey

Follow-up Survey

$60

$120

$10

$10

$10

$10

$1 deduction for every day survey is not completed after 14-day grace period

$1 deduction for every 5-day period of electronic pillbox with no charge

$1 deduction for every 5-day period with no charge, $30 bonus if returned within 2 weeks